Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Efficacy and Safety Study of XXX for the Prevention of Prostate Cancer in Men with High Grade Prostatic Intraepithelial Neoplasia (PIN)
Phase III, randomized, double-blind, placebo-controlled, parallel group study of the efficacy and safety of dutasteride to reduce the risk of biopsy-detectable prostate cancer